Reasons for Maintaining the Classification of Esmethadone as an Investigational Uncompetitive NMDAR Antagonist Rapid Antidepressant: Reply to Ferré and Michaelides.

De Martin, S., Comai, S., Mattarei, A., Kosten, T. R., Vocci, F. J., Gorodetzky, C. W., Pappagallo, M., & Manfredi, P. L. (2025). Reasons for Maintaining the Classification of Esmethadone as an Investigational Uncompetitive NMDAR Antagonist Rapid Antidepressant: Reply to Ferré and Michaelides.. The Journal of clinical psychiatry, 86. (4), 25lr15973a. https://doi.org/10.4088/JCP.25lr15973a